SPHERES : SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology, and Surveillance

Details

• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
• Description:
  Updated Apr. 9, 2021
  
  The Advanced Molecular Detection (program established the SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance (SPHERES)to coordinate SARS-CoV-2 sequencing. The SPHERES collaboration includes scientists from clinical and public health laboratories, academic institutions, and the private sector. SPHERES will strengthen COVID-19 mitigation strategies. Large-scale, rapid genomic sequencing will allow public health experts to—
  
  • Monitor important changes in the virus as it continues to circulate
  
  • Gain important insights to support contact tracing efforts
  
  • Provide crucial information to aid in identifying diagnostic and therapeutic targets
  
  • Advance public health research in the areas about transmission dynamics, host response, and evolution of the virus
  
  
• Subjects:
  Coronavirus Infections COVID-19 Genetics, Medical Genome, Human Genomics Laboratories Pandemics Public Health Practice SARS-CoV-2
• Document Type:
  Webpage
• Name as Subject:
  SPHERES : SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology, and Surveillance
• Genre:
  Map
• Place as Subject:
  United States
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:49ad740dba442aaa3515d2bd28e5ba933b9cca343630b548d34af70fff89aefe
• Download URL:
  https://stacks.cdc.gov/view/cdc/105032/cdc_105032_DS1.pdf
• File Type:
  [PDF - 518.26 KB ]